Young-soon Jang

Title: Young-soon Jang: Innovator in Anticancer Drug Development

Introduction

Young-soon Jang is a prominent inventor based in Daejon, South Korea. He has made significant contributions to the field of biomedical research, particularly in the development of anticancer agents. His innovative work focuses on targeting specific proteins involved in cancer progression.

Latest Patents

Young-soon Jang holds a patent for an anticancer drug comprising an inhibitor of TMPRSS4. This invention relates to an anticancer agent that contains a TMPRSS4 (transmembrane protease, serine 4) inhibitor as an effective ingredient. The anticancer agent can be used effectively for the treatment of cancer by inhibiting TMPRSS4 expression in cancer cells, thereby inhibiting cancer cell invasion and growth. This patent highlights his commitment to advancing cancer treatment options.

Career Highlights

Young-soon Jang is affiliated with the Korea Research Institute of Bioscience and Biotechnology. His work at this esteemed institution has allowed him to collaborate with other leading researchers in the field. His dedication to innovation and research has positioned him as a key figure in the development of new therapeutic strategies.

Collaborations

Young-soon Jang has worked alongside notable colleagues, including Young Woo Park and Semi Kim. Their collaborative efforts have contributed to the advancement of research in cancer therapies and have fostered a productive research environment.

Conclusion

Young-soon Jang's contributions to the field of anticancer drug development exemplify the impact of innovative research on healthcare. His work continues to inspire advancements in cancer treatment, showcasing the importance of targeted therapies in combating this disease.